Sotera Health Company
Sotera Health Company (SHC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
shc · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 12 Wall Street analysts in the past 3 months
Buy
12 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$24.00
Consensus
$21.50
+35.6% upside
Low
$18.00
Median: $22 · Last Close: $15.86
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$21.50
35.6% upside
High Target
$24
51.3%
Low Target
$18
13.5%
Current Price
$15.86
as of today
Based on analyst price targets, the SHC stock price prediction for the next 12 months ranges from $18 to $24. The consensus SHC price forecast of $21.50 implies 35.6% upside from the current price of $15.86.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $15.80 | ↓ 0.37% |
1-day model range: $15.76–$15.84. Peak: $15.84 (-0.37%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $14 | -10.3% |
| 2028 | $13 | -15.8% |
| 2029 | $13 | -18.9% |
| 2030 | $13 | -20.7% |
| 2031 | — | -21.8% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SHC · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-05 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-05-06 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-04-14 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-24 | Citigroup | Maintains | Buy→Buy |
| 2026-01-09 | Piper Sandler | Upgrade ↑ | Neutral→Overweight |
| 2025-11-05 | Barclays | Maintains | Overweight→Overweight |
| 2025-11-05 | JP Morgan | Maintains | Neutral→Neutral |
| 2025-11-05 | Piper Sandler | Maintains | Neutral→Neutral |
| 2025-10-02 | Barclays | Maintains | Overweight→Overweight |
| 2025-06-24 | Barclays | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Sotera Health Company (SHC) stock. Of the recent 64 rating actions, 8 were upgrades and 9 were downgrades. 12 analysts currently cover SHC.
Analyst Recommendation Trends
SHC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.2B
↓ 11.8% YoY
Revenue Next Year
$1.2B
↑ 7.0% YoY
EPS This Year
$0.84
EPS Next Year
$0.97
↑ 15.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast SHC EPS of $0.84 for the current fiscal year, based on estimates from 7 analysts. The SHC revenue forecast is $1.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SHC stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SHC price target is $21.50 (+35.6% upside), with an analyst consensus of Buy.
The SHC short-term stock prediction for tomorrow is $15.80 (-0.37%). The SHC stock price prediction for 2027 estimates an average of $14. The SHC stock prediction for 2030 projects a range of $12–$13.
Sotera Health Company trades on NASDAQ under the ticker SHC. The SHC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 92% of covering analysts.
Frequently asked questions
SHC forecast · 8 questionsAccording to 12 Wall Street analysts, the average 12-month SHC price target is $21.50, with a high forecast of $24.00 and a low of $18.00. The median price target is shown in the chart above when available. This implies +35.6% potential upside from the current price of $15.86.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.